期刊文献+

共刺激分子4-1BBL和B7-1对人T淋巴细胞的协同激发作用 被引量:1

The costimulatory effect of 4-1BBL and B7-1 molecules on human peripheral blood T lymphocyte
下载PDF
导出
摘要 目的 :探讨 4 1BBL和B7 1这 2种共刺激分子在人外周血T淋巴细胞活化、增殖中的作用和机制。方法 :采用免疫磁珠阴性选择方法分离纯化人外周血T淋巴细胞 ;单向混合淋巴细胞反应 (MLR)分析共刺激分子对T细胞的激发作用 ;3H TdR掺入法测定细胞增殖 ;免疫荧光标记和流式细胞仪表型分析 ;ELISA检测细胞因子。结果 :经免疫磁珠阴性选择分离获外周血单个核细胞中的T细胞纯度 >90 %;人多发性骨髓瘤细胞株 (XG细胞 )转染 4 1BBL和B7 1cDNA后 ,细胞膜表面能稳定高表达这 2个分子 ,4 1BBL和B7 1转基因细胞也均能使同种异体T细胞发生活化、增殖、存活时间延长和介导细胞因子IL 2的分泌 ,且 2种共刺激分子具有一定的协同效应。结论 :4 1BBL和B7 1分子具有赋予XG细胞对T细胞的体外激发、促增殖和分泌IL 2的作用 ,4 1BBL和B7 1分子能产生协同效应。 Objective:To explore the role and mechanism of 4-1BBL and B7-1 molecules in the activation and proliferation of human peripheral blood T lymphocyte. Methods:T lymphocyte was purified by magnetic beads negative selecting. The proliferation of T cells in primary allogenic MLR was evaluated by using 3H-TdR incorporation; The immunophenotype of T cells was analyzed by FACS and the quantitative measurement of IL-2 in culture supernatant were performed by ELISA.Results:After negative selection, the purity of CD3+ T cells was over 90%; 4-1BBL and B7-1 molecules stably expressed on XG cells after 4-1BBL and B7-1 cDNA transfection; 4-1BBL or B7-1 gene transfected XG cells could more effectively mediate the activation, proliferation and IL-2 secretion of T cells than XG cells did, and the results also showed that the costimulatory molecules had a co-activating effect on T cells.Conclusion:Human multiple myeloma cells failed to induced antitumor immunoresponse because of the lack or weak expression of costimulatory molecules. The costimulatory molecules of 4-1BBL and B7-1 has a synthetic effect on endowing myeloma cells with enhancing the activation、proliferation and IL-2 secretion of T cells in vitro. [
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2003年第5期295-298,共4页 Chinese Journal of Immunology
关键词 共刺激分子 4-1BBL B7-1 人T淋巴细胞 协同激发作用 Costimulatory molecules 4-1BBL/B7-1 T lymphocyte
  • 相关文献

参考文献13

  • 1Lenschow D J,Walunas T L, Bluestone J A et al. CD28/B7 system of T cell costimulation[ J]. Annu Rev Immunol, 1996; 14:233-237.
  • 2Chambers C A,Altison J P. Costintalation in T cell responses[J]. Curr Opin Immunol, 1997 ;9: 396-399.
  • 3Vinay D S, Kwon B S. Role of 4-1BB in immune responses[J].Sem Immunol, 1998; 10:481-489.
  • 4Costello R T, Fmallet D, Sainty D et al. Regulation of CD80/B7-1 and CD86/B7-2 molecular expression in human primary acute myeloid leukemia and their role in allogenic immune recognition [ J ]. Eur J Immunol,1998;28:90-98.
  • 5Cohn M,Carmons J L,Lau P et al. 4-1BB ligand induces cell indivision,sustains survial, and enhances effector function of CD4 and CD8 T cell with similar efficacy[J]. J Immunity,2001;167(3) :1313-1324.
  • 6Chambers C A, Allison J P. Costimulatory regulation of T cell function[J]. Curr Opin Cell Biol, 1999; 11(2) :203-210.
  • 7Jose C, Hurtado, Yong J et al. Signals through 4-1BB are costintalatory to preiously activated splenic T cells and inhibit activation-induced cell death[J] .J Immunity, 1997; 158:2600-2609.
  • 8Inn K, Jang Z, Lee H et al. Human 4-1BB signals are mediated by TRAF2 and activate nuclear factor -κb [ J ]. Biochemical & Biophysical Research Communications, 2000; 242: 613-620.
  • 9Martn F A,Moro M, Crosti M C et al. Vaccination with mouse manmmry adenocarcinoma cells coexpressing B7-1(CD80) and B7-2(CD86) disclose the dominant effect of B7-1 in the induction of antitumor immunity[J] .J Immunol,2000; 164(2) :698-707.
  • 10Chu N R, Debenedette M A,Stiernholm B J et al. Role of IL-12 and 4-1 BB ligand in cytokine production by CD28 + and CD28-T cells[J] .J Immunol, 1997; 158:3081-3083.

同被引文献17

  • 1Vinay DS,Choi BK,Bac JS,et al.CD137-deficientmicehavereduced NK/NKT cell numbers and function,are resistant to lipopolysaccharide-induced shock syndromes,and have lower IL-4 responses[J].J Immunol,2004,173(9):4218-4229.
  • 2Lindstedt M,Johansson LB,Borrebaeck CA.Expression of CD137(4-1 BB) on human follicular dendritic cells[J].Scand J lmmunol,2003,57(4):305-310.
  • 3Wilcox RA,Chapoval AI,Gorski KS,et al.Cutting edge:Expression of functional CD137 receptor by dendritic cells[J].Immunol,2002,168 (3):4262-4267.
  • 4Maus MV,Thomas AK,Leonard DG,et al.Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor,CD28 and 4-1BB[J].Nat Biotechnol,2002,20 (2):143-148.
  • 5Lee SW,Anthony T,et al.Enhanced CD4 T cell responsiveness in the absence of4-1BB[J].J Immunol,2005,174(7):6803 -6808.
  • 6Pauly S,Broll K,Wittmann M,et al.Cd137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers[J].J Leukoc Bio,2002,72(1):35-42.
  • 7Langstein J,Michel J,Schwarz H.CD137 induces proliferation and endomitosis in monocytes[J].Blood,1999,94(11):3161-3168.
  • 8Wilcox RA,Tamada K,Flies DB,et al.Ligation of CD137 receptor prevents and reverses established anergy of CD8 + cytolytic T lymphocytes in vivo[J].Blood,2004,103 (1):177-184.
  • 9Ye H,Park YC,Kreishman M,et al.The structural basis for the recognition of diverse receptor sequences by TRAF2[J].Mol Cell,1999,4(3):321-330.
  • 10Mittler RS,Foell J,Mccausland M,et al.Anti-CD137 antibodies in the treatment of autoimmune disease and cancer[J].Immunol Res,2004,29(1-3):197-208.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部